U
KANG

UBS’s iKang Healthcare Group, Inc. KANG Stock Holding History

UBS’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6K Buy
+300
New +$5.86K ﹤0.01% 9348

Other funds holding KANG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

UBS's KANG Position: Q3 2014 in Review

UBS opened a new position in iKang Healthcare Group, Inc. (KANG) in Q3 2014: 4,647 shares worth $91K. The stake represents ﹤0.01% of the portfolio and ranks #6107 among its holdings.

37 funds tracked by Wall St. Rank hold KANG as of Q3 2014.

  • UBS held 4,647 shares of iKang Healthcare Group, Inc. worth $91K as of Q3 2014.
  • iKang Healthcare Group, Inc. was a new UBS position in Q3 2014.
  • iKang Healthcare Group, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6107 holding.
  • 37 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.